Ginkgo Bioworks Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ginkgo Bioworks Stock Summary

Ginkgo Bioworks competes with Ocean Biomedical, Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 641 people.

Ginkgo Bioworks Key Financial Ratios

Ginkgo Bioworks Key Balance Sheet Accounts

Ginkgo Bioworks Key Income Statement Accounts

Ginkgo Bioworks Key Cash Accounts

Ginkgo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ginkgo Bioworks's current stock value. Our valuation model uses many indicators to compare Ginkgo Bioworks value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ginkgo Bioworks competition to find correlations between indicators driving Ginkgo Bioworks's intrinsic value. More Info.Ginkgo Bioworks Holdings is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . At present, Ginkgo Bioworks' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ginkgo Bioworks' earnings, one of the primary drivers of an investment's value.

Ginkgo Bioworks Holdings Systematic Risk

Today, most investors in Ginkgo Bioworks Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ginkgo Bioworks' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ginkgo Bioworks growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ginkgo Bioworks help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ginkgo Bioworks Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Ginkgo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ginkgo Bioworks's daily price indicators and compare them against related drivers.

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.